HHS Halts Funding for Development of Next-Generation COVID Biologics
by Amber Baker
The U.S. Department of Health and Human Services (DHHS) has stopped U.S. government funding for the development of next-generation COVID-19 biologics by ...
Fast-Tracked DNA-Based Therapeutic Cancer Vaccine to Be Given to Melanoma Patients in U.K.
by Natasha Hobley
Patients in England with advanced skin melanoma are receiving a “revolutionary” new therapeutic cancer vaccine in a National Health Service ...
Gates Foundation Awards $8.6 Million to Expand Development of Multi-Dose Pediatric Vaccines Using Novel Adjuvants
by TVR Staff
On Dec. 5, 2024, formulation technology company VitriVax, Inc. of Boulder, Colorado was awarded a two-year, $3.6 million grant by ...
WHO Names 17 Pathogens as Top Priorities for Global Vaccine Development
by Amber Baker
A new World Health Organization (WHO) study published in eBioMedicine last week highlights 17 viral and bacterial pathogens that are ...
Moderna/Merck’s Combo Melanoma Cancer mRNA Therapeutic May Be Ready Next Year
by TVR Staff
The CEO of Moderna, Inc., Stephane Bancel, said last week that his company may introduce a new mRNA (messenger ribonucleic ...
U.S. Government Gives Moderna $176 Million to Develop mRNA Bird Flu Biologic
by Amber Baker
On July 2, 2024, the U.S. government awarded a $176 million contract to Moderna, Inc. for the development of an ...
BARDA Awards $9.27 Million Contract to Evaluate Oral Pill COVID Vaccine
by TVR Staff
Biotechnology firm Vaxart, Inc. announced on Jan. 19, 2024 that it received a $9.27 million contract from the U.S. Biomedical ...
Only Remaining HIV Vaccine Efficacy Trial Fails in Africa
by TVR Staff
The latest effort to develop an HIV (human immunodeficiency viruses) vaccine in Uganda, Tanzania and South Africa was halted on ...
Oral Vaccine for COVID Under Development in Japan
by Carolyn Hendler, JD
Researchers in Japan have been working on a new vaccine for COVID-19 that would be administered orally rather than by ...
In this section
Latest
Popular
Comments
Latest
CDC’s ACIP Forms Workgroup to Back New Lyme Disease Vaccine and Monoclonal Antibody Products
by Carolyn Hendler, JD
Popular
Comments
San on Flu Shot Recipients “More Likely” to Get Influenza Than Unvaccinated
Mary on Flu Shot Recipients “More Likely” to Get Influenza Than Unvaccinated
Bebe on Flu Shot Recipients “More Likely” to Get Influenza Than Unvaccinated
David N. on The Truth About Whooping Cough in the U.S.
B.C. on Flu Shot Recipients “More Likely” to Get Influenza Than Unvaccinated
